Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

Journal of Intensive Care
G Umberto MeduriSamuel J Seyler

Abstract

An updated meta-analysis incorporating nine randomized trials (n = 816) investigating low-to-moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome (ARDS) show moderate-to-high quality evidence that glucocorticoid therapy is safe and reduces (i) time to endotracheal extubation, (ii) duration of hospitalization, and (iii) mortality (number to treat to save one life = 7), and increases the number of days free from (i) mechanical ventilation, (ii) intensive care unit stay, and (iii) hospitalization. Recent guideline suggests administering methylprednisolone in patients with early moderate-to-severe (1 mg/kg/day) and late persistent (2 mg/kg/day) ARDS (conditional recommendation based on moderate quality of evidence).

References

Sep 1, 1991·The American Review of Respiratory Disease·L S GreosM R Hill
Dec 17, 1987·The New England Journal of Medicine·G R BernardC A Metz
Jul 21, 1998·JAMA : the Journal of the American Medical Association·G U MeduriE A Tolley
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·M A Jantz, S A Sahn
Jan 30, 2002·British Journal of Pharmacology·Jamie D CroxtallRod J Flower
Jun 24, 2003·Journal of Pharmaceutical Sciences·Donald E MagerWilliam J Jusko
Oct 8, 2003·The Annals of Thoracic Surgery·Robert J CerfolioAlfred A Bartolucci
Nov 24, 2004·American Journal of Respiratory and Critical Care Medicine·Marco ConfalonieriG Umberto Meduri
Feb 1, 2005·The Annals of Thoracic Surgery·Hyun-Sung LeeJae Ill Zo
Dec 24, 2005·Critical Care Medicine·Djillali AnnaneUNKNOWN Ger-Inf-05 Study Group
Apr 21, 2006·The New England Journal of Medicine·Kenneth P SteinbergUNKNOWN National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network
Dec 25, 2012·International Immunopharmacology·Da TengChuan-yi Xu
Aug 18, 2016·Frontiers in Pediatrics·Gianfranco Umberto MeduriGreet Hermans
Oct 16, 2016·Critical Care : the Official Journal of the Critical Care Forum·Surat TongyooG Umberto Meduri
Jul 15, 2017·Respiratory Investigation·Sadatomo TasakaUNKNOWN Assembly of Pulmonary Circulation and Lung Injury, the Japanese Respiratory Society
Aug 5, 2017·Journal of Intensive Care·Satoru HashimotoUNKNOWN ARDS clinical practice guideline committee from the Japanese Society of Respiratory Care Medicine and the Japanese Society o
Aug 10, 2017·The New England Journal of Medicine·B Taylor ThompsonKathleen D Liu
Dec 21, 2017·Critical Care Medicine·Michael E WilsonMichelle Biehl
Jan 20, 2018·The New England Journal of Medicine·Balasubramanian VenkateshUNKNOWN ADRENAL Trial Investigators and the Australian–New Zealand Intensive Care Society Clinical Trials Group

❮ Previous
Next ❯

Citations

Aug 1, 2020·Expert Review of Respiratory Medicine·Syed Shahzad HasanSyed Tabish Razi Zaidi
Jul 1, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark W HallEng Eong Ooi
Nov 30, 2019·Expert Opinion on Investigational Drugs·Pedro Leme SilvaPatricia R M Rocco
Sep 26, 2020·Frontiers in Bioengineering and Biotechnology·Barbara DraslerBarbara Rothen-Rutishauser
Sep 29, 2019·International Journal of Molecular Sciences·Daniela MokraJuraj Mokry
Jun 27, 2019·Pediatric Allergy, Immunology, and Pulmonology·Kirsten E OrloffKyle J Rehder
May 8, 2020·Critical Care : the Official Journal of the Critical Care Forum·Xu Li, Xiaochun Ma
Oct 8, 2020·Intensive Care Medicine·Yaseen M ArabiG Umberto Meduri
Aug 14, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christiane Maria Prado JeronimoUNKNOWN Metcovid Team
Jan 12, 2021·The Lancet. Respiratory Medicine·Luigi CamporotaUNKNOWN NHS England ECMO Service
Dec 4, 2020·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Takatomo HirouchiMasaharu Shinkai
Jan 6, 2021·Critical Care : the Official Journal of the Critical Care Forum·Pablo MonederoUNKNOWN COVID-19 Spanish ICU Network
Dec 2, 2020·ERJ Open Research·Joe ZhangChristopher I S Meadows
Jan 7, 2021·Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine·Subodh J SaggiMoro O Salifu
Feb 16, 2021·Expert Review of Clinical Pharmacology·Harmanjit SinghAshish Kumar Kakkar
Feb 27, 2021·Journal of Intensive Care Medicine·Justine J KoRenli Qiao
Feb 12, 2020·The Lancet. Respiratory Medicine·Jesús VillarUNKNOWN dexamethasone in ARDS network
Mar 7, 2021·International Journal of Molecular Sciences·Daniela Mokra, Juraj Mokry
Mar 6, 2021·Frontiers in Cardiovascular Medicine·Yonghao LanYujie Zhou
Jan 20, 2021·Physiological Research·D Mokrá
Mar 26, 2021·Clinical Medicine : Journal of the Royal College of Physicians of London·Asad AnwarBrendan Madden
Apr 21, 2021·Intensive Care Medicine·Dipayan ChaudhuriBram Rochwerg
Jun 1, 2021·Critical Care Clinics·Evan S Schwarz
Jul 22, 2021·Infection and Drug Resistance·Zheng LiuDong-Fang Zhao
Jul 30, 2021·Public Health·M Fernandes, J Brábek
Nov 17, 2021·Expert Opinion on Pharmacotherapy·Maria Gabriella MateraMario Cazzola
Sep 30, 2020·British Journal of Anaesthesia·Peter B SherrenLuigi Camporota
Jan 14, 2022·Open Forum Infectious Diseases·Seema JoshiMayur Ramesh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.